Keyphrases
Acquired Demyelinating Syndromes
16%
Amygdala
26%
Antiepileptic Drugs
44%
Australia
32%
Blind People
17%
Brain MRI
16%
Brain Networks
17%
Callosal
45%
Callosum
18%
Cerebral Small Vessel Disease (cSVD)
18%
Child Mental Health
17%
Cognitive Decline
16%
Cognitive Function
21%
Cognitive Impairment
23%
Corpus Callosum
95%
Corpus Callosum Agenesis
56%
Cortical Thickness
21%
COVID-19 Pandemic
22%
Epilepsy
16%
Executive Function
38%
Frailty
21%
Frontal Region
16%
Functional Connectivity
23%
Functional Magnetic Resonance Imaging
39%
Gait
24%
Generalized Social Anxiety Disorder
28%
Healthy Controls
19%
Interhemispheric
17%
Laterality
22%
Magnetic Resonance Imaging
44%
Magnetoencephalography
28%
Mental Health
21%
Morphometric Similarity
21%
Neurobehavior
22%
Neurodevelopmental Outcome
20%
Older People
17%
Oxytocin
35%
Parental Mental Illness
19%
Pediatric
28%
Pediatric Traumatic Brain Injury
37%
Polytherapy
17%
Population-based Study
25%
Processing Speed
18%
School-age children
28%
Size-and-shape
45%
Sodium Valproate
30%
Structural Magnetic Resonance Imaging (sMRI)
33%
Type 2 Diabetes Mellitus (T2DM)
21%
Valproate
50%
Women with Epilepsy
15%
Neuroscience
Agenesis of the Corpus Callosum
49%
Amygdala
31%
Anterior Commissure
17%
Anticonvulsant
16%
Autism Spectrum Disorder
11%
Autoantibodies
8%
Behavior (Neuroscience)
8%
Bipolar Disorder
18%
Brain Activation
8%
Brain Disease
8%
Brain Network
25%
Cerebrovascular Accident
34%
Cerebrovascular Disease
28%
Cognitive Disorders
27%
Cognitive Function
47%
Corpus Callosum
100%
Demyelinating Disease
14%
Dorsolateral Prefrontal Cortex
10%
Encephalitis
21%
Executive Function
37%
Face
19%
Focal Epilepsy
10%
Frontal Lobe
21%
Functional Connectivity
33%
Functional Magnetic Resonance Imaging
47%
Gray Matter
23%
Hemispheric Dominance
24%
Hippocampus
11%
Hyperactivity
8%
In Vivo
11%
Inferior Frontal Gyrus
10%
Magnetic Resonance Imaging
66%
Magnetic Resonance Imaging
57%
Magnetic Resonance Imaging of Brain
12%
Magnetoencephalography
35%
Myelin Oligodendrocyte Glycoprotein
17%
Neurotrauma
42%
Oxytocin
35%
Pervasive Developmental Disorder
12%
Placebo
10%
Posterior Commissure
12%
Social Anxiety Disorder
28%
Social Cognition
9%
Sodium Valproate
15%
Splenium
10%
Structural Magnetic Resonance Imaging
7%
Temporal Lobe
23%
Temporal Lobe Epilepsy
15%
Tractography
14%
Traumatic Brain Injury
42%